TCRβ+CD8+CD4+ cells, which only constituted between 0.22 and 3.4% of CD45+ lymphocytes in unaffected and 0.2–4% in tumor tissue, were also insufficient for functional experiments. This evidence concerns the gene CD8A and neoplasm.